TrialClinical cancer research : an official journal of the American Association for Cancer Research2026
Computationally Derived Spatial Immune Signature Identifies Trastuzumab Responders in HER2+ Breast Cancer: NSABP B-41 Clinical Trial Validation.
Satvika Bharadwaj et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.